Vaxxinity, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 56.93 million compared to USD 75.22 million a year ago. Basic loss per share from continuing operations was USD 0.45 compared to USD 0.6 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0868 USD | -7.66% | +44.67% | -89.79% |
May. 13 | Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P Global BMI Index | CI |
May. 13 | Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-89.79% | 11.91M | |
+41.68% | 54.04B | |
+43.57% | 41.96B | |
-1.13% | 41.92B | |
-7.59% | 28.35B | |
+12.22% | 26.35B | |
-22.46% | 19B | |
+7.84% | 13B | |
+29.16% | 12.28B | |
+25.14% | 12.19B |
- Stock Market
- Equities
- VAXX Stock
- News Vaxxinity, Inc.
- Vaxxinity, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023